These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
932 related articles for article (PubMed ID: 16767666)
1. [Relationship between paraoxonase 1 55 Met/Leu, paraoxonase 2 148 Ala/Gly genetic polymorphisms and coronary artery disease]. Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP Zhonghua Yi Xue Yi Chuan Xue Za Zhi; 2006 Jun; 23(3):289-93. PubMed ID: 16767666 [TBL] [Abstract][Full Text] [Related]
2. [Study of the association between paraoxonase1 55 Met/Leu, paraoxonase2 148 Ala/Gly and manganese superoxide dismutase (MnSOD) 9 Ala/Val genetic polymorphisms and coronary heart disease]. Chi DS; Ling WH; Ma J; Xia M; Hou MJ; Wang Q; Zhu HL; Tang ZH; Yu XP Zhonghua Liu Xing Bing Xue Za Zhi; 2006 Sep; 27(9):808-13. PubMed ID: 17299970 [TBL] [Abstract][Full Text] [Related]
3. PON1 M/L55 mutation protects high-risk patients against coronary artery disease. Oliveira SA; Mansur AP; Ribeiro CC; Ramires JA; Annichino-Bizzacchi JM Int J Cardiol; 2004 Mar; 94(1):73-7. PubMed ID: 14996478 [TBL] [Abstract][Full Text] [Related]
4. A preliminary study of human paraoxonase and PON 1 L/M55-PON 1 Q/R 192 polymorphisms in Turkish patients with coronary artery disease. Kaman D; Ilhan N; Metin K; Akbulut M; Ustündağ B Cell Biochem Funct; 2009 Mar; 27(2):88-92. PubMed ID: 19226538 [TBL] [Abstract][Full Text] [Related]
5. Low paraoxonase activity in type II diabetes mellitus complicated by retinopathy. Mackness B; Durrington PN; Abuashia B; Boulton AJ; Mackness MI Clin Sci (Lond); 2000 Mar; 98(3):355-63. PubMed ID: 10677395 [TBL] [Abstract][Full Text] [Related]
6. Human paraoxonase gene polymorphisms and coronary artery disease risk. Mendonça MI; Dos Reis RP; Freitas AI; Sousa AC; Pereira A; Faria P; Gomes S; Silva B; Santos N; Serrão M; Ornelas I; Freitas S; Araújo JJ; Brehm A; Cardoso AA Rev Port Cardiol; 2008 Dec; 27(12):1539-55. PubMed ID: 19280995 [TBL] [Abstract][Full Text] [Related]
7. [Association of paraoxonase polymorphisms and serum homocysteine thiolactone complex with coronary heart disease]. Qin Q; Li YL; Zhao FM; Wang H; Li Y; Cui RZ; Zhao BR Zhonghua Xin Xue Guan Bing Za Zhi; 2006 Sep; 34(9):803-7. PubMed ID: 17217688 [TBL] [Abstract][Full Text] [Related]
8. [The relationship between paraoxanase gene Leu-Met (55) and Gln-Arg (192) polymorphisms and coronary artery disease]. Taşkiran P; Cam SF; Sekuri C; Tüzün N; Alioğlu E; Altintaş N; Berdeli A Turk Kardiyol Dern Ars; 2009 Oct; 37(7):473-8. PubMed ID: 20098041 [TBL] [Abstract][Full Text] [Related]
9. Paraoxonase polymorphisms PON1 192 and 55 and longevity in Italian centenarians and Irish nonagenarians. A pooled analysis. Rea IM; McKeown PP; McMaster D; Young IS; Patterson C; Savage MJ; Belton C; Marchegiani F; Olivieri F; Bonafe M; Franceschi C Exp Gerontol; 2004 Apr; 39(4):629-35. PubMed ID: 15050299 [TBL] [Abstract][Full Text] [Related]
10. Detecting the polymorphisms of paraoxonase (PON) cluster in Chinese Han population based on a rapid method. Zhang Y; Zheng F; Du H; Krepinsky JC; Segbo JA; Zhou X Clin Chim Acta; 2006 Mar; 365(1-2):98-103. PubMed ID: 16185677 [TBL] [Abstract][Full Text] [Related]
11. Combined impact of matrix metalloproteinase-3 and paraoxonase 1 55/192 gene variants on coronary artery disease in Turkish patients. Ozkök E; Aydin M; Babalik E; Ozbek Z; Ince N; Kara I Med Sci Monit; 2008 Oct; 14(10):CR536-42. PubMed ID: 18830194 [TBL] [Abstract][Full Text] [Related]
12. Hyperhomocysteinemia, paraoxonase activity and risk of coronary artery disease. Kerkeni M; Addad F; Chauffert M; Chuniaud L; Miled A; Trivin F; Maaroufi K Clin Biochem; 2006 Aug; 39(8):821-5. PubMed ID: 16875684 [TBL] [Abstract][Full Text] [Related]
13. Paraoxonase 55 and 192 polymorphism and its relationship to serum paraoxonase activity and serum lipids in Turkish patients with non-insulin dependent diabetes mellitus. Agachan B; Yilmaz H; Karaali Z; Isbir T Cell Biochem Funct; 2004; 22(3):163-8. PubMed ID: 15124181 [TBL] [Abstract][Full Text] [Related]
14. Associations between genetic polymorphisms of paraoxonase genes and coronary artery disease in a Taiwanese population. Chen CC; Chen CC; Tu JD; Wu YL; Leu SJ Clin Biochem; 2013 Nov; 46(16-17):1664-7. PubMed ID: 23742759 [TBL] [Abstract][Full Text] [Related]
15. Determinants of homocysteine-thiolactonase activity of the paraoxonase-1 (PON1) protein in humans. Lacinski M; Skorupski W; Cieslinski A; Sokolowska J; Trzeciak WH; Jakubowski H Cell Mol Biol (Noisy-le-grand); 2004 Dec; 50(8):885-93. PubMed ID: 15704252 [TBL] [Abstract][Full Text] [Related]
16. Is paraoxonase 192 gene polymorphism a risk factor for membranoproliferative glomerulonephritis in children? Bilge I; Sirin A; Agachan B; Emre S; Sadikoglu B; Yilmaz H; Sucu A; Isbir T Cell Biochem Funct; 2007; 25(2):159-65. PubMed ID: 16175651 [TBL] [Abstract][Full Text] [Related]
17. [Low paraoxonase and arylesterase plasma activities in Mexican patients with coronary artery disease]. Gamboa R; Regalado JC; Huesca-Gómez C; Posadas-Romero C; Verdejo Paris J; Vargas-Alarcón G; Pérez-Méndez O Arch Cardiol Mex; 2008; 78(4):360-8. PubMed ID: 19205543 [TBL] [Abstract][Full Text] [Related]
18. Association of homocysteine thiolactonase activity and PON1 polymorphisms with the severity of acute coronary syndrome. Koubaa N; Nakbi A; Hammami S; Attia N; Mehri S; Ben Hamda K; Ben Farhat M; Miled A; Hammami M Clin Biochem; 2009 Jun; 42(9):771-6. PubMed ID: 19269283 [TBL] [Abstract][Full Text] [Related]
19. Paraoxonase/arylesterase ratio, PON1 192Q/R polymorphism and PON1 status are associated with increased risk of ischemic stroke. Can Demirdöğen B; Türkanoğlu A; Bek S; Sanisoğlu Y; Demirkaya S; Vural O; Arinç E; Adali O Clin Biochem; 2008 Jan; 41(1-2):1-9. PubMed ID: 17920578 [TBL] [Abstract][Full Text] [Related]
20. Paraoxonase-1 genetic polymorphisms and susceptibility to DNA damage in workers occupationally exposed to organophosphate pesticides. Singh S; Kumar V; Thakur S; Banerjee BD; Rautela RS; Grover SS; Rawat DS; Pasha ST; Jain SK; Ichhpujani RL; Rai A Toxicol Appl Pharmacol; 2011 Apr; 252(2):130-7. PubMed ID: 21291901 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]